White DL, Thrift AP, Kanwal F, et al.. Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology 2017;152:812–820.e5.
Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 2016;150:835–853.
European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2018;69:182–236.
Heimbach JK, Kulik LM, Finn RS, et al.. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018;67:358–380.
Fong ZV, Tanabe KK. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer 2014;120:2824–2838.
Cho YK, Kim JK, Kim MY, et al.. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009;49:453–459.
Lin S, Hoffmann K, Schemmer P. Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer 2012;1:144–158.
Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429–442.
Simonetti RG, Liberati A, Angiolini C, et al.. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 1997;8:117–136.
El-Serag HB, Siegel AB, Davila JA, et al.. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol 2006;44:158–166.
Sonnenday CJ, Dimick JB, Schulick RD, et al.. Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma. J Gastrointest Surg 2007;11:1636–1646.
Altekruse SF, Henley SJ, Cucinelli JE, et al.. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol 2014;109:542–553.
Franco RA, Fan Y, Jarosek S, et al.. Racial and geographic disparities in hepatocellular carcinoma outcomes. Am J Prev Med 2018;55(Suppl 1):S40–48.
Gornick ME, Warren JL, Eggers PW, et al.. Thirty years of Medicare: impact on the covered population. Health Care Financ Rev 1996;18:179–237.
Warren JL, Klabunde CN, Schrag D, et al.. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40(8 Suppl):IV-3–18.
Dartmouth Atlas Project. Understanding geographic variations in health care. Accessed October 9, 2019. Available at: http://www.dartmouthatlas.org
Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181–200.
Chirica M, Scatton O, Massault PP, et al.. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery? Arch Surg 2008;143:538–543.
Hanazaki K, Kajikawa S, Shimozawa N, et al.. A 15-year retrospective study of hepatic resection for stage IV-A hepatocellular carcinoma shows value in hepatitis B negative patients. Am J Surg 2002;183:89–94.
Poon RT, Fan ST, Ng IO, et al.. Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification. Ann Surg 2003;237:376–383.
Shimada M, Takenaka K, Kawahara N, et al.. Surgical treatment strategy for patients with stage IV hepatocellular carcinoma. Surgery 1996;119:517–522.
Elixhauser A, Steiner C, Harris DR, et al.. Comorbidity measures for use with administrative data. Med Care 1998;36:8–27.
Islami F, Miller KD, Siegel RL, et al.. Disparities in liver cancer occurrence in the United States by race/ethnicity and state. CA Cancer J Clin 2017;67:273–289.
Cronin KA, Lake AJ, Scott S, et al.. Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer 2018;124:2785–2800.
Lauerer M, Kaiser K, Nagel E. Organ transplantation in the face of donor shortage: ethical implications with a focus on liver allocation. Visc Med 2016;32:278–285.
New Mexico Department of Health. The State of Health in New Mexico 2018. Accessed October 9, 2019. Available at: https://nmhealth.org/publication/view/report/4442/
United States Census Bureau. Population and Housing Unit Estimates. Accessed October 9, 2019. Available at: https://www.census.gov/programs-surveys/popest.html
Aizer AA, Chen MH, McCarthy EP, et al.. Marital status and survival in patients with cancer. J Clin Oncol 2013;31:3869–3876.
Galati G, Dell’Unto C, Vespasiani-Gentilucci U, et al.. Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances. Rev Recent Clin Trials 2016;11:238–252.
Kuo KL, Stenehjem D, Albright F, et al.. Treatment patterns and outcomes in patients with hepatocellular carcinoma stratified by stage-guided treatment categories. J Natl Compr Canc Netw 2015;13:987–994.
Poon RT, Fan ST, Lo CM, et al.. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000;18:1094–1101.
Chen VL, Le AK, Kim NG, et al.. Effects of cirrhosis on short-term and long-term survival of patients with hepatitis B-related hepatocellular carcinoma. Clin Gastroenterol Hepatol 2016;14:887–895.e1.
Nathan H, Hyder O, Mayo SC, et al.. Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-Medicare analysis. Ann Surg 2013;258:1022–1027.
Centers for Medicare & Medicaid Services. 2019 Medicare Trustees Report. Accessed October 9, 2019. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ReportsTrustFunds/Downloads/TR2019.pdf